| [1] |
Ivarsson MA, Michaëlsson J, Fauriat C. Activating killer cell Ig-like receptors in health and disease[J]. Front Immunol, 2014(5):184.
|
| [2] |
Albrecht C, Malzahn D, Brameier M, et al. Progression to AIDS in SIV-infected Rhesus macaques is associated with distinct KIR and MHC class I polymorphisms and NK cell dysfunction[J]. Front Immunol, 2014(5):600.
|
| [3] |
Björkström NK, Béziat V, Cichocki F, et al. CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells[J]. Blood, 2012, 120(17):3455-3465.
|
| [4] |
Giebel S, Boratyn-Nowicka A, Karabon L, et al. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer[J]. Hum Immunol, 2014, 75(6):508-513.
|
| [5] |
Dutta A, Saikia N, Phookan J, et al. Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma[J]. Immunogenetics, 2014, 66(7/8):439-448.
|
| [6] |
Grifoni A, Montesano C, Patronov A, et al. Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction[J]. Biomed Res Int, 2013:283805.
|
| [7] |
Purdy AK, Campbell KS. Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR) [J]. Cancer Biol Ther, 2009, 8(23):2211-2220.
|
| [8] |
Thompson A, van der Slik AR, Koning F, et al. An improved RT-PCR method for the detection of killer-cell immunoglobulin-like receptor (KIR) transcripts[J]. Immunogenetics, 2006, 58(11):865-872.
|
| [9] |
Robinson J, Halliwell JA, McWilliam H, et al. IPD: the Immuno Polymorphism Database[DB]. Nucleic Acids Res, 2013 (41):D1234-1240.
|
| [10] |
Jamil KM, Khakoo SI. KIR/HLA interactions and pathogen immunity[J]. J Biomed Biotechnol, 2011:298348.
|
| [11] |
Rolstad B. The early days of NK cells: an example of how a phenomenon led to detection of a novel immune receptor system-lessons from a rat model[J]. Front Immunol, 2014(5):283.
|
| [12] |
Cassidy SA, Cheent KS, Khakoo SI. Effects of Peptide on NK cell-mediated MHC I recognition[J]. Front Immunol, 2014(5):133.
|
| [13] |
Davis CT, Rizzieri D. Immunotherapeutic applications of NK cells. Pharmaceuticals, 2015, 8(2):250-256.
|
| [14] |
Naumova E, Mihaylova A, Stoitchkov K, et al. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals[J]. Cancer Immunol Immunother, 2005, 54(2):172-178.
|
| [15] |
de Smith AJ, Walsh KM, Ladner MB, et al. The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia[J]. Blood, 2014, 123(16):2497-2503.
|
| [16] |
Pan N, Jiang W, Sun H, et al. KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study[J]. PLoS One, 2011, 6(10):e25682.
|
| [17] |
De Re V, Caggiari L, De Zorzi M, et al. Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases[J]. PLoS One, 2015, 10(2):e0117420.
|